Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
The landmark ruling came as the Honorable Supreme Court of India has declared that safe…
West Bengal is one of the most culturally rich states in India. It is famous…
The India-New Zealand Free Trade Agreement was signed at the Bharat Mandapam in New Delhi.…
The World Day for Safety and Health at Work 2026 is observed on the 28th…
India has many mountain ranges that shape its land, climate and rivers. These mountains act…
India has delivered the strong performance at the ISSF Junior World Cup 2026 in the…